FDA Investigator Gerald N Mcgirl, DDS

Gerald N Mcgirl, DDS has inspections in 26 countries as of 12 Jan 2023. Gerald N Mcgirl, DDS has collaborated with a combinined 1716 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
118
Last Inspection Date:
12 Jan 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Ukraine, South Africa, Canada, Poland, Germany, Singapore, Romania, Netherlands, Argentina, United States of America, Croatia, Chile, Italy, Denmark, Brazil, United Kingdom of Great Britain and Northern Ireland, France, Australia, Finland, Belgium, India, Peru, Austria, Russian Federation, Hong Kong
Co-Investigator(s):
Alla Dubrovsky, Allen F Hall, Andrea A Branche, Anthony E Keller, RPh, Barbara A Crowl, Carl Lee, CDR Rochelle B Young, RPh, MSA, Charles M Kerns, BLT DO, Christina V Santos, Christine M Parmentier, Constance Lewin, MD, Craig A Garmendia, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, Cynthia L Rakestraw, Darlene B Almogela, David R Heiar, Dawn C Olenjack, Deborah A Nebenzahl, Diane Cvan Leeuwen, Dr. Sriram Subramaniam, PhD, Edward D Harris, Eric W Anderson, Erin L Mcfiren, Gajendiran Mahadevan, PhD, Himanshu Gupta, PhD, James F Mccormack, PhD, James M Kewley, James P Stumpff, Jeffrey M Watson, Jeffrey W Shrifter, DPM, Joanne Hosting, John A Gonzalez, Joseph P Iser, MD, Ka L Wong, Kara A Scheibner, PhD, Kathleen B Swat, Kathryn A Krentz, Kathryn D Macropol, Kenneth S Boehnen, Kevin P Foley, Khin Mu, MD, Kristin M Abaonza, Lance M De Souza, MBA, Lawton W Lum, LT Melanie M Mayor, USPHS, Maida Henesian (NMI), Maria Pkelly Doggett, MBA, Mark C Saale, Mark E Chan, Mark F Chan, Marshalette O Edwards, Martin K Yau, PhD, Mary T Carden, Michael A Taylor, Michael D Skelly, PhD, Michael F Skelly, PhD, Michael P Sheehan, Michelle D Haamid, Michelle M Noe, Michelle M Noe Varga, N Mcgirl, DDS, Nancy A Bellamy, Ni Aye Khin, MD, Nicola M Fenty Stewart, Patrick D Stone, MS, Paula J Perry, Peter E Baker, Ralph A Erickson, Raymond T Oji, Robert D Tollefsen, Robert W Jennings, Rose M Ashley, Roy R Rinc, Sandra A Hughes, Sandra L Shire, DMD, MPA, Sandra S Saniga, Scott B Laufenberg, Sergio Chavez (NMI), Shelley H Beausoleil, Sripal R Mada, PhD, Stephen D Brown, Steven E Kane, Steven Eastham, Tania K Mercado, Teena H Aiken, Terrance L Thomas, Thea C Grome, Thomas W Gordon, Timothy C Grome, Yehualashet A Gessesse

Gerald N Mcgirl, DDS's Documents

Publish Date Document Type Title
March, 2000 EIR Professor Alpheus M. Segone - EIR, 2000-03-31
November, 2002 EIR Claude Labrie, M.D., Ph.D. - EIR, 2006-08-17
February, 2001 EIR Wolitz, Richard A., M.D. - EIR, 2001-02-09
October, 2001 FDA 483 Bellinger, Raye L - Form 483, 2001-10-05
September, 2000 FDA 483 Klinicki bolnicki centar Zagreb - Form 483, 2000-09-01
August, 2002 EIR Dr. AJ Dowson - EIR, 2002-09-16
April, 2000 EIR Dr. Marletta Van Den Berg - EIR, 2000-06-08
August, 2002 FDA 483 NUVISAN GmbH - Form 483, 2002-08-23
April, 2000 FDA 483 Zeier, Dr. Michele D. - Form 483, 2000-05-31
March, 2001 FDA 483 Irwin, David H., M.D. - Form 483, 2001-03-12
March, 2000 FDA 483 Professor Alpheus M. Segone - Form 483, 2000-03-31
August, 2002 FDA 483 Pharma Bio-Research Group Bv - Form 483, 2002-08-29
September, 2000 EIR Prof. Vera Folnegovic-Smalc, M.D., ScD - EIR, 2000-09-26
July, 2002 EIR Bayer Healthcare, LLC - EIR, 2002-07-11
April, 2000 EIR Dr. Michele D. Zeier - EIR, 2000-05-31
September, 2000 FDA 483 Prof. Vera Folnegovic-Smalc, M.D., ScD - Form 483, 2000-09-07
October, 2001 EIR Bellinger, Raye L - EIR, 2001-10-05
March, 2001 EIR Irwin, David H., M.D. - EIR, 2001-03-14
April, 2007 EIR Ellina Melynk - EIR, 2007-04-05
July, 2002 FDA 483 Bayer Healthcare, LLC - Form 483, 2002-07-11
April, 2000 FDA 483 Response Dr. Marletta Van Den Berg - Form 483R, 2000-07-12
July, 2002 FDA 483 Bayer Healthcare, LLC - Form 483, 2002-07-09
December, 2000 FDA 483 Response Dr. Peter Berger - Form 483R, 2001-02-12
April, 2000 EIR Dr. Michele D. Zeier - EIR, 2000-04-12
April, 2000 FDA 483 Response Dr. Michele D. Zeier - Form 483R, 2000-04-12
October, 2001 FDA 483 Response Bellinger, Raye L - Form 483R, 2001-10-25
August, 2002 EIR Pharma Bio-Research Group Bv - EIR, 2002-09-26
September, 2000 FDA 483 Response Prof. Vera Folnegovic-Smalc, M.D., ScD - Form 483R, 2000-09-07
December, 2003 EIR Charles W. Lynde, MD - EIR, 2003-12-05
December, 2000 EIR Dr. Peter Berger - EIR, 2001-01-17
April, 2000 FDA 483 Response Professor Darryl J. Sleep - Form 483R, 2000-04-05
March, 2000 FDA 483 Response Professor Alpheus M. Segone - Form 483R, 2000-12-18
December, 2004 FDA 483 Professor Paul Cales, M.D. - Form 483, 2004-12-17
August, 2002 EIR NUVISAN GmbH - EIR, 2002-09-26
April, 2002 EIR Karen Lam, M.D./Ming-sun Nelson Wat, M.D. - EIR, 2002-04-18
February, 2001 FDA 483 Wolitz, Richard A., M.D. - Form 483, 2001-02-09
March, 2001 FDA 483 Response Irwin, David H., M.D. - Form 483R, 2001-03-13
December, 2004 EIR Professor Paul Cales, M.D. - EIR, 2005-01-26
September, 2000 EIR Miro Jakovljevic, M.D. - EIR, 2000-09-26
April, 2000 FDA 483 Kalafong Hospital - Form 483, 2000-04-05
April, 2002 FDA 483 Response Juliana C.N. Chan, M.D. - Form 483R, 2002-04-22
April, 2002 EIR Juliana C.N. Chan, M.D. - EIR, 2002-04-12
September, 2000 FDA 483 Response Miro Jakovljevic, M.D. - Form 483R, 2000-10-16
December, 2002 EIR Audrey S. Petroukhin, M.D., Ph.D. - EIR, 2002-12-13
May, 2004 EIR Dr. Riitta Jokinen, M.D. - EIR, 2004-05-10
April, 2000 EIR Professor Darryl J. Sleep - EIR, 2000-04-05
April, 2002 FDA 483 Juliana C.N. Chan, M.D. - Form 483, 2002-04-12
August, 2002 FDA 483 Response Pharma Bio-Research Group Bv - Form 483R, 2002-09-20
December, 2003 FDA 483 Charles W. Lynde, MD - Form 483, 2003-12-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more